Work

Evaluating Coffee and Caffeine Intake in Adults with Cardiovascular Disease: A Comparative Literature Review

Year: 2025
Type: article
Study design: Systematic Review
Abstract: Coffee is among the most commonly consumed beverages worldwide, and its bioactive components, including caffeine, affect the cardiovascular system through multiple physiological mechanisms. Patients with cardiovascular disease are typically advised to limit coffee and caffeine consumption because of potential cardiovascular harm, but emerging research challenges this recommendation. This review evaluates recent evidence regarding consumption of whole coffee, caffeine, or decaffeinated coffee in adults with established cardiovascular disease. Database searches conducted across three platforms for studies published after December 2021 yielded 360 records. Following screening against inclusion criteria, 11 studies were reviewed included in the final review. The studies showed variable results among three primary adult population diagnoses: stable cardiovascular disease, hypertension (controlled and uncontrolled), and atrial fibrillation. Among the studies, 1-4 cups of coffee per day was associated with neutral or reduced cardiovascular risk, while intake exceeding four cups was associated with increased cardiovascular risk, indicating a threshold effect dose-response pattern. In patients with uncontrolled cardiovascular disease or severe hypertension, caffeine exposure was associated to elevated cardiovascular risk. Caffeine intake less than 400mg per day was not consistently associated with increased cardiovascular risk. The inconsistencies in the studies reflect inherent limitations of observational nutritional research. Improved methodological standardization is necessary to determine causal pathways and inform evidenced-based dietary practice for patients with cardiovascular disease.
Language: English
Field: Medicine
Open Access status: green
OpenAlex ID: W7161930677
FWCI:
Cites: 22
Cited by:
Related to: 10